Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127181) titled 'The application of new technology in the auxiliary diagnosis, curative effect evaluation, prognosis judgment and recurrence monitoring of Pan cancer' on June 26.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: Benign and malignant pulmonary nodules:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=329729
Published by HT Digital Content Servic...